Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

IBIO, INC. (IBIO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

IBIO, INC. (IBIO), most recent 12 months reported: revenue $100K, net loss $33.04M, free cash flow -$23.8M. Latest balance sheet on file: liquid cash $88.04M. From SEC filings. Others in Pharmaceutical Preparations: Lisata Therapeutics, Inc. · Serina Therapeutics, Inc. · VYOME HOLDINGS, INC. · BULLFROG AI HOLDINGS, INC. · ASPIRE BIOPHARMA HOLDINGS, INC. · Actinium Pharmaceuticals, Inc. · AVALO THERAPEUTICS, INC. · SILO PHARMA, INC.

Stock screener

Watchlist